Full Breakdown
Appeals Court to Hear Challenge to RFK Jr.’s Vaccine-Schedule Overhaul
By Drooid · · How we work
Court Hearing on the Lawsuit
A federal appeals court will hear arguments on Tuesday in a lawsuit filed by a coalition of medical organizations seeking to block the childhood vaccine schedule changes championed by Health Secretary Robert F. Kennedy Jr. The case is before the U.S. Court of Appeals for the First Circuit.
Background: Recent Changes to Vaccine Recommendations
In January, Kennedy and the Centers for Disease Control and Prevention (CDC) announced a reduction in the number of diseases for which routine childhood vaccination is recommended, cutting the list from 18 to 11. The CDC also removed universal recommendations for hepatitis A, hepatitis B, respiratory syncytial virus (RSV), dengue, and two bacterial meningitis vaccines. In addition, Kennedy dismissed every member of the CDC’s Advisory Committee on Immunization Practices and appointed individuals described as highly skeptical of vaccines.
Legal Claims and Prior Rulings
The lawsuit, led by the American Academy of Pediatrics and joined by the American College of Physicians and the Society for Maternal-Fetal Medicine, alleges that the Department of Health and Human Services (HHS) violated the Administrative Procedure Act and that the schedule revisions were “arbitrary and capricious.” The plaintiffs argue that changes to vaccine recommendations must be grounded in scientific justification, warning that weakening current guidance could lower coverage, increase vaccine hesitancy, and raise the risk of preventable disease spread and mortality.
A district-court judge previously ruled in favor of the medical groups, issuing a temporary injunction that blocked the new schedule and paused any actions by the advisory committee. The Trump administration appealed that decision, leading to the upcoming appellate hearing.
Potential Implications
If the appeals court upholds the injunction, the revised schedule would remain halted, preserving the existing CDC recommendations. Conversely, a reversal could allow the reduced vaccine list and the new advisory committee composition to take effect, potentially reshaping U.S. childhood immunization policy and influencing public-health outcomes nationwide.